Search

Author/Creator Gallegos, Isabel

1. Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients. (February 2020)

Authors:
Cortés, Javier; Ciruelos, Eva; Pérez-García, José; Albanell, Joan; García-Estévez, Laura; Ruiz–Borrego, Manuel; Espinosa, Ruth; Gallegos, Isabel; González, Santiago; Álvarez, Isabel; Llombart, Antonio
Journal:
Cancer treatment reviews
Issue:
Volume 83(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies. Issue 6 (3rd June 2018)

Authors:
Castellano, Daniel; Maroto, José Pablo; Espinosa, Enrique; Grande, Enrique; Bolós, M Victoria; Llinares, Julia; Esteban, Emilio; González del Alba, Aranzazu; Climent, Miguel Angel; Arranz, Jose Angel; Méndez, Mª José; Fernández Parra, Eva; Antón-Aparicio, Luis; Bayona, Cristina; Gallegos, Isabel;...
Journal:
Expert opinion on drug safety
Issue:
Volume 17:Issue 6(2018)
Page Start:
573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP). (December 2020)

Authors:
Manso, Luis; Hernando, Cristina; Galán, María; Oliveira, Mafalda; Cabrera, Miguel A.; Bratos, Raquel; Rodríguez, César A.; Ruiz-Borrego, Manuel; Blanch, Salvador; Llombart-Cussac, Antonio; Delgado-Mingorance, Juan I.; Álvarez-Busto, Iñaki; Gallegos, Isabel; González-Cortijo, Lucía; Morales, Seraf...
Journal:
Breast
Issue:
Volume 54(2020)
Page Start:
286
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗